Venous thromboembolism and pregnancy

Obstet Gynecol Clin North Am. 2001 Sep;28(3):613-30. doi: 10.1016/s0889-8545(05)70222-9.

Abstract

Venous thromboembolism remains a major cause of maternal morbidity and mortality. Pregnancy is a thrombogenic state; therefore, clinicians must be familiar with the diagnosis and treatment of acute VTE. It is of paramount importance when caring for pregnant women to understand which patients are at risk for VTE and to use thromboprophylactic heparin accordingly.

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Female
  • Heparin / adverse effects
  • Heparin / pharmacokinetics
  • Heparin / therapeutic use*
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / pharmacokinetics
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / diagnosis
  • Pregnancy Complications, Cardiovascular / drug therapy*
  • Pregnancy Complications, Cardiovascular / prevention & control
  • Thromboembolism / diagnosis
  • Thromboembolism / drug therapy*
  • Thromboembolism / prevention & control
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Heparin